Sign In Forgot Password

COVID-19: A Conversation from the Front Line

Wednesday, June 3, 2020 11 Sivan 5780

5:00 PM - 6:00 PMOnline
COVID-19: A Conversation from the Front Line
The Future of COVID-19: Can Israeli Technology and Innovation Change the Course of the Pandemic?
Dr. Daniel Kraft and Steven Schoenfeld interviewed by Dr. Jonathan Graf
Wednesday, June 3, 5 pm
 
Join us for a conversation between Dr. Daniel Kraft, a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator; Steven Schoenfeld, the Founder and Chief Investment Officer of BlueStar Indexes; and Dr. Jonathan Graf, professor of medicine at UCSF and a practicing internist and rheumatologist at Zuckerberg San Francisco General and UCSF Medical Centers.
 
Sherith Israel is lucky to have a few experts who will spend some time talking about what they are seeing, working on, and planning for in their fields. Interviewed by our host, Dr. Jonathan Graf, this is sure to be an informative opportunity to hear from and ask questions of our guests.
 
Please submit questions for consideration by email to programs@sherithisrael.org by Friday, May 29.

Zoom Meeting Info:

Web or Mobile App One tap mobile Dial By Location

Join Us on Zoom

Meeting ID: 981 7235 0291
Password: 9icMUY

+16699006833,,98172350291#,,1#,742762# +1 669 900 6833
Meeting ID: 981 7235 0291
Password: 742762


 

Dr. Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur, and innovator. With over 25 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has chaired the Medicine for Singularity University  since its inception in 2008, and is founder and chair of Exponential Medicine, a program that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.

 

Steven Schoenfeld is the Founder and Chief Investment Officer of BlueStar Indexes which maintains a family of indexes for Global Technology Stocks, Emerging Markets and Israeli Equities and Bonds. Steven is a 36-year veteran of the investment management industry, having served in senior fiduciary positions at Northern Trust, where he oversaw more $300 billion in global equity and fixed income portfolios, and at Barclays Global Investors (now Blackrock), where he managed more than $70 billion in developed and emerging market stock index fund and ETFs.  Previously, he led the team at the World Bank which developed the first investable Emerging Market indexes, and traded Japanese stock index futures on the floor of the Singapore Exchange.

Dr. Jonathan Graf is a professor of medicine at the University of California at San Francisco and a practicing internist and rheumatologist at Zuckerberg San Francisco General and UCSF Medical Centers. He specializes in autoimmune and rheumatic diseases such as rheumatoid arthritis and is the director of the UCSF Rheumatoid Arthritis cohort. His research focuses in part on rheumatoid arthritis and the relationship between chronic inflammation and heart disease. He also studies biomarkers and precision guided therapy in the treatment of autoimmune diseases. He graduated summa cum laude from the University of Pennsylvania, where he also received a medical degree. He did his residency in internal medicine and fellowship in rheumatology at UCSF and joined the faculty in 2003. He has won numerous UCSF teaching awards and been elected a UCSF Department  of Medicine Master Clinician. He is married to Rabbi Jessica Zimmerman Graf.

Share Print Save To My Calendar
Wed, September 23 2020 5 Tishrei 5781